Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cluneal nerve impingement injection comparison study
ACTRN12622000603718Phase 3Not yet recruiting
- Sponsor
- Jennifer Saunders
- Start
- Apr 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone, lidocaine and glucose in cluneal nerve entrapment syndrome (CNES) (2 arms), sponsored by Jennifer Saunders. Primary endpoints: Visual Analog Scale pain score, Roland Morris Back Pain Disability Index and 1 more. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
dexamethasonelidocaineglucose
03
Conditions
cluneal nerve entrapment syndrome (CNES)
Beyond the preview
Go deeper on ACTRN12622000603718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000603718.